Interview in Next Generation Pharmaceutical

NGP gathers industry experts of Cisbio, MILabs, PerkinElmer and Roche to discuss the current drug development space. Prof. Beekman, CEO/CSO Milabs states that drug development can, and needs to become, much faster and effective by using novel tools that facilitate early selection of potentially successful drug leads.

Link to full article